Industry News
-
Genprex Licenses Exclusive Patent for Quaratusugene Ozeplasmid Gene Therapy in Mesothelioma
Apr 28 2025 -
BlackfinBio Receives FDA Clearance to Initiate Phase 1/2 Clinical Trial of Novel Gene Therapy BFB-101 for Rare Neurological Disorder SPG47
Apr 28 2025 -
DAAN and GC Cell agree on CAR T, CAR-NK therapies
Apr 22 2025 -
Exclusive: George Church startup will study long-lived animals, humans to find life-extending genes
Apr 22 2025 -
Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen (AGT)-Targeting siRNA Drug for Hypertension
Apr 21 2025 -
FDA grants breakthrough status to uniQure’s Huntington’s therapy
Apr 21 2025 -
Exosomes: What They Do and Who’s Doing What
Apr 21 2025 -
New Strategy Enhances CRISPR Editing Efficiency for Therapeutic Use
Apr 18 2025 -
uniQure’s AMT-130 Receives FDA Breakthrough Therapy Designation for Huntington’s Disease
Apr 17 2025